Table 2.
Phospholipid metabolites associated with metabolic dysfunction progression in non-obese individuals.
| Metabolite | Sub-Pathway | Estimate | SE | p-Value | FDR |
|---|---|---|---|---|---|
| Choline phosphate | Phospholipid Metabolism | 0.232 | 0.045 | 2.52 × 10−7 | 2.69 × 10−6 |
| Glycerophosphoethanolamine | Phospholipid Metabolism | 0.186 | 0.041 | 7.09 × 10−6 | 5.38 × 10−5 |
| Choline | Phospholipid Metabolism | −0.199 | 0.047 | 3.08 × 10−5 | 2.06 × 10−4 |
| Glycerophosphorylcholine (GPC) | Phospholipid Metabolism | 0.139 | 0.045 | 2.21 × 10−3 | 8.36 × 10−3 |
| Trimethylamine N-oxide | Phospholipid Metabolism | −0.108 | 0.041 | 9.01 × 10−3 | 2.82 × 10−2 |
FDR significance of 0.05 was used.